PLANET GREEN HOLDINGS CORP Net Income 2006-2021 | PLAG

PLANET GREEN HOLDINGS CORP net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
PLANET GREEN HOLDINGS CORP Annual Net Income
(Millions of US $)
2020 $-11
2019 $3
2018 $21
2017 $-63
2016 $-136
2015 $3
2014 $4
2013 $17
2012 $20
2011 $20
2010 $18
2009 $14
2008 $15
2007 $10
2006 $6
2005 $4
PLANET GREEN HOLDINGS CORP Quarterly Net Income
(Millions of US $)
2021-06-30 $-1
2021-03-31 $-1
2020-12-31 $-2
2020-09-30 $-8
2020-06-30 $-0
2020-03-31 $-1
2019-12-31 $6
2019-09-30 $-3
2019-06-30 $-0
2019-03-31 $0
2018-12-31 $-25
2018-09-30 $47
2018-06-30 $-1
2018-03-31 $-0
2017-12-31 $-51
2017-09-30 $5
2017-06-30 $-2
2017-03-31 $-15
2016-12-31 $-133
2016-09-30 $0
2016-06-30 $0
2016-03-31 $-3
2015-12-31 $1
2015-09-30 $2
2015-06-30 $-0
2015-03-31 $-0
2014-12-31 $-1
2014-09-30 $1
2014-06-30 $2
2014-03-31 $2
2013-12-31 $7
2013-09-30 $4
2013-06-30 $3
2013-03-31 $3
2012-12-31 $8
2012-09-30 $5
2012-06-30 $3
2012-03-31 $4
2011-12-31 $7
2011-09-30 $7
2011-06-30 $3
2011-03-31 $2
2010-12-31 $8
2010-09-30 $5
2010-06-30 $3
2010-03-31 $2
2009-12-31 $6
2009-09-30 $4
2009-06-30 $2
2009-03-31 $2
2008-12-31 $6
2008-09-30 $4
2008-06-30 $2
2008-03-31 $2
2007-12-31 $6
2007-09-30 $2
2007-06-30 $-0
2007-03-31 $2
2006-12-31 $-0
2006-09-30 $2
2006-06-30 $1
2006-03-31 $-0
2005-12-31 $-0
2005-09-30 $-0
2005-06-30 $-0
2005-03-31 $-0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.039B $0.004B
Planet Green Holdings Corp is a biotechnology enterprise. It provides artificial intelligence integrates extraction, R&D, production and sales from natural plants. Planet Green Holdings Corp., formerly known as American Lorain Corporation, is based in China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86